Jane Street’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-19,233
Closed -$167K – 10343
2022
Q4
$167K Sell
19,233
-4,676
-20% -$37.6K ﹤0.01% 7800
2022
Q3
$143K Sell
23,909
-2,213
-8% -$12K ﹤0.01% 8441
2022
Q2
$141K Sell
26,122
-30
-0.1% -$162 ﹤0.01% 8447
2022
Q1
$123K Sell
26,152
-3,647
-12% -$19.1K ﹤0.01% 9354
2021
Q4
$146K Sell
29,799
-21,057
-41% -$104K ﹤0.01% 9021
2021
Q3
$393K Sell
50,856
-3,398
-6% -$29.1K ﹤0.01% 7710
2021
Q2
$633K Buy
+54,254
New +$824K ﹤0.01% 6803

Other funds holding VECT

Jane Street's VECT Position: Q1 2023 in Review

Jane Street sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q1 2023, closing a stake of 19,233 shares — an estimated $167K sold.

Jane Street first reported a position in VECT in Q2 2021 and held it in 7 quarters. The position peaked at $633K in Q2 2021. 35 funds tracked by Wall St. Rank hold VECT as of Q1 2023.

  • Jane Street reported no remaining VectivBio Holding AG Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 19,233 VectivBio Holding AG Ordinary Shares shares in Q1 2023, an estimated $167K.
  • Jane Street first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 7 quarters.
  • Jane Street's VectivBio Holding AG Ordinary Shares position peaked at $633K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.